Over six million people in nine districts of West Bengal, India are exposed to very high levels of arsenic primarily through their drinking water. More than 300,000 people showed arsenic-induced skin lesions in these districts. This is regarded as the greatest arsenic calamity in the world. Chronic arsenicosis causes varied dermatological signs ranging from pigmentation changes, hyperkeratosis to non-melanocytic cancer of skin, and also malignancies in different internal organs. Higher incidences of opportunistic infections are found in the arsenic-exposed individuals, indicating that their immune systems may be impaired somehow. We have thus investigated the effect of arsenic on T-cell proliferation and cytokine secretion in 20 individuals with arsenic-induced skin lesions and compared the results with 18 arsenic-unexposed individuals. A marked dose-dependent suppression of Concanavalin A (Con A) induced T-cell proliferation was observed in the arsenic-exposed individuals compared with the unexposed (P < 0.001) individuals. This correlated with a significant decrease in the levels of secreted cytokines by the T cells (TNF-α, IFN-γ, IL2, IL10, IL5, and IL4) in the exposed individuals (P < 0.001). Thus it can be inferred that arsenic exposure can cause immunosuppression in humans.
1 Kyle RA Sunderman FW Sunderman FW . Inorganic arsenic intoxication. In: Laboratory diagnosis of disease caused by toxic agents; Sunderman FW and Sunderman (Jr) FW, Budapest, Elsevier Scientific Publishing Company, New York, USA. 1970. p. 367–370.
2.
2 Su C Puls RW . Arsenate and arsenite removal by zerovalent iron: kinetics, redox transformation, and implications for in situ groundwater remediation. Environ Sci Technol2001; 7: 1487–1492.
3.
3 WHO Guidelines for drinking water quality. Health criteria and other supporting information. 2nd ed. Geneva: WHO Guidelines for drinking water quality; 1996; 2: 940–994.
4.
4 Frost FJ Muller T Petersen HV Thomson B Tollestrup K . Identifying US populations for the study of health effects related to drinking water arsenic. J Expo Anal Environ Epidemiol2003; 13: 231–239.
5.
5 Ghosh P Basu A Mahata J Basu S Sengupta M Das JK . Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water. Int J Cancer2006; 118: 2470–2478.
6.
6 Mandal BK Chowdhury TR Samanta G Basu GK Chowdhury PP Chanda CR . Arsenic in ground water in seven districts of West Bengal, India-the biggest arsenic calamity in the world. Curr Sci1996; 70: 976–986.
7.
7 Guha Mazumder DN Haque R Ghosh N De BK Santra A Chakraborty D . Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol1998; 27: 871–877.
8.
8 Haque R Mazumder DN Samanta S Ghosh N Kalman D Smith MM . Arsenic in drinking water and skin lesions: dose- response data from West Bengal, India. Epidemiology2003; 14: 174–182.
9.
9 Rahman MM Chowdhury UK Mukherjee SC Mondal BK Paul K Lodh D . Chronic arsenic toxicity in Bangladesh and West Bengal, India- a review and commentary. Clin Toxicol2001; 39: 683–700.
10.
10 Wegman PO Gonsebatt ME Montero R Vega L Barba H Espinosa J . Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mutat Res1991; 250: 477–482.
11.
11 Gonsebatt ME Vega L Herrera LA Montero R Rojas E Cebrián ME . Inorganic arsenic effects on human lymphocyte stimulation and proliferation. Mutat Res1992; 283: 91–95.
12.
12 Vega L Gonsebatt ME Wegman PO . Aneugenic effects of sodium arsenite on human lymphocytes in vitro: an individual susceptibility effect detected. Mutat Res1995; 334: 365–373.
13.
13 Hsu YH Li SY Chiou HY Yeh PM Liou JC Hsueh YM . Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowens disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan. Mutat Res1997; 386: 241–251.
14.
14 Basu A Mahata J Roy AK Sarkar JN Poddar G Nandy AK . Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res2002; 516: 29–40.
15.
15 Basu A Ghosh P Das JK Banerjee A Ray K Giri AK . Micronuclei as biomarkers of carcinogen exposure in populations exposed to arsenic through drinking water in West Bengal, India: a comparative study in 3 cell types. Cancer Epidemiol Biomarkers Prev2004; 13: 820–827.
16.
16 Mahata J Basu A Ghoshal S Sarkar JN Roy AK Poddar G . Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res2003; 534: 133–143.
17.
17 Tseng CH . The potential biological mechanisms of arsenic induced diabetes mellitus. Toxicol Appl Pharmacol2004; 197: 67–83.
18.
18 Vega L Ostrosky-Wegman P Fortoul TI Díaz C Madrid V Saavedra R . Sodium arsenite reduces proliferation of human activated T-cells by inhibition of the secretion of interleukin-2. Immunopharmacol Immunotoxicol1999; 2: 203–220.
19.
19 Das D Chatterjee A Mandal BK Samanta G Chakraborti D Chanda B . Arsenic in groundwater in six districts of West Bengal, India: the biggest arsenic calamity in the world. II. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst1995; 120: 917–924.
20.
20 Kiaki K Ishige M Kobayashi S Bingyan W Kumagai M Day NK . Suppression of T- cell proliferation by CD8 + T Cells induced in the presence of Protoscolices of Echinococcus multilocularis in vitro. Infect Immun1993; 61: 525–533.
21.
21 Jimenez R Ramírez R Carracedo J Agüera M Navarro D Santamaría R . Cytometric bead array (CBA) for the measurement of cytokines in urine and plasma of patients undergoing renal rejection. Cytokine2005; 32: 45–50.
22.
22 Galicia G Leyva R Tenorio EP Ostrosky WP . Saavedra, Rl. Sodium arsenite retards proliferation of PHA-activated T cells by delaying the production and secretion of IL-2. Int Immunopharmacol2003; 3: 671–677.
23.
23 Gonsebatt ME Vega L Montero R Garcia-Vargas G Del Razo LM Albores A . Lymphocyte replicating ability in individuals exposed to arsenic via drinking water. Mutat Res1994; 313: 671–682.
24.
24 Gerson AS Ana LL Leonor AS Patricia CM Lizbeth LC Mariano EC . Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J2006; 6: 779–781.
25.
25 Kulkarni GV Mc Culloch CA . Concanavalin A induced apoptosis in fibroblasts: the role of cell surface carbohydrates in lectin mediated cytotoxicity. J Cell Physiol1995; 165: 119–133.
26.
26 Sengupta M Bishayi B . Effect of lead and arsenic on murine macrophage response. Drug Chem Toxicol2002; 4: 459–472.
27.
27 Zheng-Wu L Dai WJ Wang GL Lin ZB . Subchronic in vivo treatments of morphine inhibit T cell proliferation by acting on macrophages. Brain Behav Immun1996; 10: 351–363.
28.
28 Rappaport RS Dodge GR . Prostaglandin E inhibits the production of human interleukin 2. J Exp Med1982; 155: 943–948.
29.
29 Romagnani S . Lymphokine production by human T cells in disease states. Annu Rev Immunol1994; 12: 227–257.
30.
30 Mocci S Coffman RL . Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J Immunol1995; 154: 3779–3787.
31.
31 Elsasser-Beile U von Kleist S Sauther W Gallati H Mönting JS . Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages. Br J Cancer1993; 68: 32–36.
32.
32 Wanebo HJ Pace R Hargett S Katz D Sando J . Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. Cancer1986; 57: 656–662.
33.
33 Kuo WR Yu HS Chang KL Juan KH Jan YS Yu CL . Increased production of tumor necrosis factor-α and release of soluble CD4 and CD8 molecules, but decreased responsiveness to phytohemagglutinin in patients with nasopharyngeal carcinoma. J Formos Med Assoc1994; 93: 569–575.
34.
34 Romagnani S . Lymphokine production by human T cells in disease states. Annu Rev Immunol1994; 12: 227–257.
35.
35 Bradley LM Dalton DK Croft M . A direct role for IFN-γ in regulation of Th1 cell development. J Immunol1996; 157: 1350–1358.
36.
36 Thomas DJ Styblo M Lin S . The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol2001; 176: 127–144.
